Wedbush restated their outperform rating on shares of PepGen (NASDAQ:PEPG – Free Report) in a research report report published on Tuesday morning, Benzinga reports. They currently have a $21.00 price target on the stock. PepGen Stock Performance NASDAQ:PEPG opened at $11.66 on Tuesday. The company has a market capitalization of $277.62 million, a price-to-earnings ratio […]
PepGen (NASDAQ:PEPG – Get Free Report) and Affimed (NASDAQ:AFMD – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends. Insider and Institutional Ownership 71.8% of PepGen shares are […]
HC Wainwright reiterated their buy rating on shares of PepGen (NASDAQ:PEPG – Free Report) in a research report report published on Thursday, Benzinga reports. The firm currently has a $26.00 target price on the stock. Separately, SVB Securities cut their price objective on PepGen from $33.00 to $28.00 in a research report on Wednesday, June […]
PepGen Inc. (NASDAQ:PEPG – Free Report) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 293,900 shares, a growth of 49.9% from the May 31st total of 196,000 shares. Based on an average daily volume of 60,500 shares, the short-interest ratio is presently […]
PepGen Inc. (NASDAQ:PEPG – Get Rating) CEO James G. Mcarthur sold 1,800 shares of the firm’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $16.04, for a total value of $28,872.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which […]